Cite

HARVARD Citation

    Schapira, A. et al. (n.d.). Long‐term efficacy and safety of safinamide as add‐on therapy in early Parkinson's disease. European journal of neurology. 20 (2), pp. 271-280. [Online]. 
  
Back to record